SCHEMBL18924951

SCHEMBL18924951

CNc1ncnc(C(=O)O)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.43
YTHDC1 Q96MU7 3/20 0.37
YTHDF2 Q9Y5A9 2/20 0.37
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
CYP2C19 P33261 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HCAR3 P49019 1/20 0.34
PDPK1 O15530 1/20 0.34
MKNK2 Q9HBH9 2/20 0.34
MKNK1 Q9BUB5 1/20 0.34
MAPT P10636 1/20 0.33
EGFR P00533 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
CSNK2A2 P19784 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17623066 0.85 YTHDC1 (0.37) KMOYTHDC1YTHDF2ALDH1A1KDM4E
SCHEMBL13472462 0.79 HCAR3 (0.33) KMOYTHDC1YTHDF2ALDH1A1KDM4E
SCHEMBL13472317 0.79 KMO (0.39) KMOYTHDC1YTHDF2HCAR3PDPK1
SCHEMBL18809682 0.79 SMN1; SMN2 (0.38) KMOALDH1A1KDM4EHSD17B10MKNK2
SCHEMBL18809723 0.77 GAA (0.46) ALDH1A1KDM4EHSD17B10CSNK2A2CSNK2B
SCHEMBL14567010 0.76 YTHDC1 (0.48) YTHDC1YTHDF2ALDH1A1KDM4ECYP1A2
SCHEMBL7763434 0.75 KMO (0.47) KMOALDH1A1KDM4ECYP3A4HPGD
SCHEMBL12591005 0.75 ADORA2A (0.33) KMOYTHDC1YTHDF2HCAR3PDPK1
SCHEMBL2259692 0.74 KMO (0.46) KMOALDH1A1KDM4ECYP3A4ALOX15
SCHEMBL28069552 0.73 KMO (0.43) KMOALDH1A1KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670222-B2 CCR2 receptor antagonists and uses thereof CENTREXION THERAPEUTICS CORPORATION (US) 2017-06-06 US disclosed